Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2026-05-28 Report Publication Anno…
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 90% confidence The document is a short letter to stock exchanges notifying that the audio recording of the company’s earnings call (discussion of financial results for the quarter and year ended March 31, 2026) is now available on the company’s website. It does not contain actual financial data or the full transcript, but simply announces the publication of the call audio. Under the “menu vs meal” rule, this fits as a Report Publication Announcement rather than an earnings report or transcript itself.
2026-05-28 English
Newspaper Publication of Audited Financial Results is enclosed herewith.
Earnings Release Classification · 89% confidence The document is an official stock‐exchange filing under SEBI LODR (Reg. 30 & 47) providing extract of audited quarterly and annual financial results via a newspaper advertisement. It contains actual results tables (statement of audited financial results for quarter and year ended 31 Mar 2026) rather than merely announcing the timing of a report. This fits the definition of an initial earnings release (ER), not a simple report publication notice or full annual/interim report. FY 2026
2026-05-28 English
Copy of Newspaper Publication
Earnings Release Classification · 75% confidence The document is a statutory letter under SEBI LODR Regulations 30 and 47 enclosing the newspaper advertisement (in Financial Express and Loksatta) which publishes extracts of the audited financial results for the quarter and year ended March 31, 2026. It contains the key highlights—revenue, net profit, EPS—typical of a first‐time release of periodical financial results. This matches the definition of an Earnings Release rather than a full annual report or simple notice of publication. FY 2026
2026-05-28 English
Enclosed herewith is the Press Release.
Earnings Release Classification · 83% confidence The document is a press release announcing the audited financial results for Q4 and full year ended March 31, 2026, with key consolidated financial highlights and metrics. It is the initial public earnings announcement rather than a full annual report or certification, so it fits the Earnings Release category. FY 2026
2026-05-28 English
Press Release
Earnings Release Classification · 89% confidence The document is a press release submitted to stock exchanges announcing the Board’s approval of audited financial results for Q4 FY26 and full year FY26, including key revenue, EBITDA, PAT, and EPS highlights. It is not the full annual or quarterly report but rather an initial summary of periodical results, fitting the definition of an Earnings Release (ER). FY 2026
2026-05-28 English
Investor Presentation enclosed herewith.
Investor Presentation Classification · 98% confidence The document is titled “Investor Presentation” and contains detailed slides, financial highlights (Q4 & FY26 P&L, balance sheet), business overview, strategy, and charts – exactly fitting the definition of an Investor Presentation. It is not merely an announcement of results, nor a call transcript or standalone report. Therefore, it is classified as IP (Investor Presentation).
2026-05-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.